{
    "$schema": "../schema.json",
    "meta": {
        "id": "nirmatrelvir-paxlovid-pfizer-unknown-2024",
        "molecule_name": "Nirmatrelvir (Paxlovid Pfizer)",
        "class": "Natural Product",
        "author": "Unknown",
        "year": 2024
    },
    "sequence": [
        {
            "step_id": "1",
            "reaction_type": "Deprotonation / Acid-Base Reaction",
            "reagents": "LiOH",
            "reagent_smiles": "",
            "conditions": "THF, H2O",
            "yield": "88%",
            "reactant_smiles": "CC1(C)[C@H]2CN[C@@H]([C@H]21)C(=O)OC.Cl",
            "product_smiles": "CC1(C)[C@H]2CN[C@@H]([C@H]21)C(=O)OC",
            "notes": "Conversion of an amine hydrochloride salt to its free base using LiOH. The methyl ester group remains unchanged.",
            "substeps": []
        },
        {
            "step_id": "2",
            "reaction_type": "Amidation / Acylation",
            "reagents": "TsCl, DMAP, Et3NH",
            "reagent_smiles": "CC(C)(C)[C@@H](C(=O)O)NC(=O)C(F)(F)F",
            "conditions": "THF",
            "yield": "58%",
            "reactant_smiles": "CC1(C)[C@H]2CN[C@@H]([C@H]21)C(=O)OC",
            "product_smiles": "CC(C)(C)[C@@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)OC)C2(C)C)NC(=O)C(F)(F)F",
            "notes": "Acylation of the pyrrolidine secondary amine with the trifluoroacetyl-protected amino acid to form an amide bond.",
            "substeps": []
        },
        {
            "step_id": "3",
            "reaction_type": "Peptide Coupling / Amide Formation",
            "reagents": "HOPO, DIPEA, EDCI",
            "reagent_smiles": "N[C@@H](CC1CC[C@H](C1=O)N)C(=O)N.Cl",
            "conditions": "MEK",
            "yield": "",
            "reactant_smiles": "CC(C)(C)[C@@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)OC)C2(C)C)NC(=O)C(F)(F)F",
            "product_smiles": "CC(C)(C)[C@@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@@H](C[C@H]3CC[C@H](C3=O)N)C(=O)N)C2(C)C)NC(=O)C(F)(F)F",
            "notes": "Methyl ester converted to amide by coupling with an amino amide hydrochloride.",
            "substeps": [
                {
                    "step_id": "3.1",
                    "reaction_type": "Alkylation",
                    "reagents": "LiHMDS",
                    "reagent_smiles": "C(C#N)Br",
                    "conditions": "",
                    "yield": "",
                    "reactant_smiles": "[Boc]N[C@@H](C(=O)OC)CCCC(=O)OC",
                    "product_smiles": "[Boc]N[C@@H](C(=O)OC)C[C@H](C(=O)OC)CC#N",
                    "notes": "Alkylation of an ester enolate with bromoacetonitrile to form a new chiral center and extend the side chain.",
                    "substeps": []
                },
                {
                    "step_id": "3.2",
                    "reaction_type": "Reductive Cyclization",
                    "reagents": "H2, NH4Cl, Raney Ni",
                    "reagent_smiles": "",
                    "conditions": "MeOH, H2O",
                    "yield": "",
                    "reactant_smiles": "[Boc]N[C@@H](C[C@H](CC#N)C(=O)OC)C(=O)OC",
                    "product_smiles": "[Boc]N[C@@H](C[C@@H]1CCNC1=O)C(=O)OC",
                    "notes": "Reductive cyclization of a nitrile and an ester to form a pyrrolidinone lactam. One methyl ester and the Boc protecting group remain untouched.",
                    "substeps": []
                },
                {
                    "step_id": "3.3",
                    "reaction_type": "Deprotection",
                    "reagents": "TsOH, i-PrOH, MTBE",
                    "reagent_smiles": "Cc1ccc(S(=O)(=O)O)cc1.CC(C)O.CC(C)(C)OC",
                    "conditions": "",
                    "yield": "",
                    "reactant_smiles": "[Boc]N[C@H](C[C@H]1CCNC1=O)C(=O)OC",
                    "product_smiles": "COC(=O)[C@H](C[C@H]1CCNC1=O)N.[TsOH]",
                    "notes": "Boc deprotection of an alpha-amino acid methyl ester using TsOH.",
                    "substeps": []
                },
                {
                    "step_id": "3.4",
                    "reaction_type": "Amide formation / Ester Ammonolysis",
                    "reagents": "NH3, MgSO4, HCl",
                    "reagent_smiles": "",
                    "conditions": "MeOH, i-PrOH, DMF",
                    "yield": "",
                    "reactant_smiles": "COC(=O)[C@H](C[C@@H]1CCNC1=O)N.Cc1ccc(S(=O)(=O)O)cc1",
                    "product_smiles": "[NH3+][C@H](C[C@@H]1CCNC1=O)C(=O)N.[Cl-]",
                    "notes": "Ammonolysis of a methyl ester to a primary amide. The counterion is exchanged from p-toluenesulfonic acid (TsOH) to hydrochloric acid (HCl). Stereochemistry at both chiral centers is maintained.",
                    "substeps": []
                }
            ]
        },
        {
            "step_id": "4",
            "reaction_type": "Dehydration",
            "reagents": "TFAA, NMM",
            "reagent_smiles": "FC(F)(F)C(=O)OC(=O)C(F)(F)F.CN1CCOCC1",
            "conditions": "i-PrOAc, Then H2O, MTBE",
            "yield": "80%",
            "reactant_smiles": "CC(C)(C)[C@@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@@H](C[C@@H]3CCNC3=O)C(=O)N)C2(C)C)NC(=O)C(F)(F)F",
            "product_smiles": "CC(C)(C)[C@@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@@H](C[C@@H]3CCNC3=O)C#N)C2(C)C)NC(=O)C(F)(F)F",
            "notes": "Dehydration of the C-terminal primary amide to form a nitrile using trifluoroacetic anhydride (TFAA) and N-methylmorpholine (NMM).",
            "substeps": []
        },
        {
            "step_id": "5",
            "reaction_type": "Purification/Crystallization",
            "reagents": "i-PrOAc, heptane",
            "reagent_smiles": "",
            "conditions": "i-PrOAc, heptane",
            "yield": "94%",
            "reactant_smiles": "CC(C)(C)[C@@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@@H](C[C@H]3CC(=O)N3)C#N)C2(C)C)NC(=O)C(F)(F)F",
            "product_smiles": "CC(C)(C)[C@@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@@H](C[C@H]3CC(=O)N3)C#N)C2(C)C)NC(=O)C(F)(F)F",
            "notes": "No chemical transformation observed; the reactant and product structures are identical (Nirmatrelvir). This step likely represents a purification or crystallization.",
            "substeps": []
        }
    ]
}